Bayesian clinical trial designs another option for trauma trials? Erratum by Jansen, Jan O et al.
 ERRATUM 
In issue 83.4 of The Journal of Trauma and Acute Care Surgery, in the article by Jansen et al., 
Table 2's data was overestimated. Table 2's data has been updated with the corrected probabilities, 
with the Bayesian success criterion relaxed to 0.8. (Informative priors will also be used in the 
trial’s final analysis.) 
Table 2. Stopping and success probabilities and expected sample sizes in UK-REBOA (based on a 
non-informative prior) 
Odds 
Ratio 
Survival Probability of declaring Expected  
sample 
size  
Futility 
(1st) 
Futility 
(2nd) 
Futility 
(final) 
Futility 
(total) 
Success 
0.70 58.2% 22.3% 13.8% 9.9% 46.1% 4.0%  96.6 
0.80 61.4% 17.0% 10.2% 7.3% 34.5% 7.9% 102.4 
0.90 64.1% 13.0% 7.4% 5.1% 25.4% 13.3% 106.7 
1.00 66.5% 10.0% 5.3% 3.5% 18.7% 19.9% 109.9 
1.10 68.6% 7.8% 3.7% 2.3% 13.8% 27.2% 112.3 
1.20 70.4% 6.1% 2.7% 1.5% 10.3% 35.0% 114.1 
1.30 72.1% 4.8% 1.9% 1.0% 7.7% 42.7% 115.4 
1.40 73.5% 3.8% 1.4% 0.6% 5.8% 50.1% 116.4 
1.50 74.9% 3.1% 1.0% 0.4% 4.4% 57.0% 117.2 
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